Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial Results

Twist Bioscience Corporation (TWST) Tops Q4 EPS by 16c, Revenues Beat

November 23, 2020 7:25 AM EST

Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.54), $0.16 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $32.43 million versus the consensus estimate of $22.67 million.

FISCAL 2020 FOURTH QUARTER FINANCIAL RESULTS

Orders: Total orders received for the fourth quarter of fiscal 2020 were $42.7 million, compared to $20.0 million for the same period of fiscal 2019.Revenue: Total revenues were $32.4 million for the fourth quarter of fiscal 2020 compared to $15.7 million for the same period of fiscal 2019.Cost of Revenues: Cost of revenues for the fourth quarter of fiscal 2020 was $17.6 million... More